Back

Myla P. Lai-Goldman, M.D.

Chair and Former Chief Executive Officer and President, GeneCentric Therapeutics, inc. Director since 2014

Dr. Lai-Goldman is the Chair of GeneCentric Therapeutics, Inc.—a precision medicine company— where she previously served as CEO and President since June 2011. She is also managing partner of Personalized Science, LLC, a clinical diagnostic consulting company that she founded in 2008. Previously, Dr. Lai-Goldman was CEO and Chief Scientific Officer of CancerGuide Diagnostics, Inc. Before joining CancerGuide Diagnostics, she held various roles including Executive Vice President, Chief Medical Officer and Chief Scientific Officer—at Laboratory Corporation of America Holdings (LabCorp) and its predecessor company, Roche Biomedical Laboratories, Inc. Additionally, Dr. Lai-Goldman has been a venture partner at Hatteras Venture Partners since August 2011. Dr. Lai-Goldman is Board-certified in anatomic and clinical pathology. She now serves as a board member for Quanterix Corporation, NovoPath, and Mercy BioAnalytics. She previously served as a director of Akoya Biosciences, Inc. and Qvella Corporation.

  • Member of the Audit Committee